# Horner syndrome as a postoperative complication of thyroid surgery: a systematic review

**Authors:** Tianhao Xie, Yan Fu, Xiaoshi Jin, Qingxu Meng, Yang Liu, Xiaoshuang Liu, Zheng Niu, Xinli Sun, Lingyun Liu

PMC · DOI: 10.3389/fendo.2025.1664870 · Frontiers in Endocrinology · 2025-10-01

## TL;DR

This review highlights Horner Syndrome as a rare but important complication of thyroid surgery, affecting 0.25% of patients, with higher rates in open surgery and children.

## Contribution

The study systematically quantifies the incidence and risk factors of Horner Syndrome after thyroid surgery using PRISMA guidelines.

## Key findings

- Horner Syndrome occurred in 0.25% of thyroid surgery cases, with higher rates in open surgery (0.41%) and children (1.84%).
- Most cases (67.5%) were associated with malignant thyroid conditions, and symptoms typically appeared within 3 days post-surgery.
- Short-term steroid and neurotrophic therapy showed some efficacy, with most patients recovering within a year.

## Abstract

This systematic review aims to enhance surgeons’ awareness of Horner Syndrome (HS) as a rare yet significant complication following thyroid surgery (TS).

Web of Science, PubMed, Cochrane Library, and Embase.

Based on the PRISMA framework, a comprehensive literature search was conducted covering the period from January 1, 2000, to June 1, 2025.

Out of the 308 articles retrieved, 50 were included in this review, comprising 14 case series and 36 case reports. These studies documented a total of 40 cases of HS following TS. The overall incidence of HS was found to be 0.25%, with a higher incidence in open surgery (0.41%) compared to endoscopic surgery (0.15%). The incidence rate among children undergoing open surgery was 1.84%, which was higher than that among adults (0.22%). Malignant cases accounted for 67.5%, while benign cases represented the remaining 32.5%. HS symptoms typically manifested within 3 days post-surgery, with ptosis being the most common presentation. It rarely affects ocular function but may lead to decreased vision or heterochromia. Short-term steroid and neurotrophic therapy demonstrated some efficacy in alleviating symptoms, and complete recovery was more likely to occur within one year.

HS represents a rare yet significant complication of TS, primarily attributed to surgical trauma to the cervical sympathetic chain (CSC). Clinicians must remain vigilant regarding this complication and employ meticulous surgical techniques to prevent CSC injury.

## Linked entities

- **Diseases:** Horner Syndrome (MONDO:0001294)

## Full-text entities

- **Diseases:** HS (MESH:D006732), ptosis (MESH:C564553), heterochromia (MESH:C538115), decreased (MESH:D009123), CSC injury (MESH:D012019), TS (MESH:D013966), trauma (MESH:D014947)
- **Chemicals:** steroid (MESH:D013256)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12520952/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12520952/full.md

## References

77 references — full list in the complete paper: https://tomesphere.com/paper/PMC12520952/full.md

---
Source: https://tomesphere.com/paper/PMC12520952